January 25, 2024 C-Path Promotes Cécile Ollivier to Vice President of Global Affairs, Expanding Leadership in Drug Development Critical Path Institute (C-Path) today announced the promotion of Cécile Ollivier, M.S., from Managing Director, Europe to...
January 22, 2024 C-Path’s TRxA Announces its 2024 Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced...
January 18, 2024 Patient Engagement Webinar Hosted by SFA Sarcoma Foundation of America is dedicated to fostering the development of innovative treatment options for those...
January 16, 2024 C-Path weighs in on key topics to advance Real-World Data and Artificial Intelligence in Rare Diseases Vice President, Cécile Ollivier, serves on a panel of distinguished experts in the EJP RD-EFPIA Joint Advanced Webinar on...
January 11, 2024 C-Path to Lead New Task Force Aimed at Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases Critical Path Institute (C-Path) today announced the launch of a task force focused on accelerating drug...
January 9, 2024 Best Practice Recommendations for Electronic Clinical Outcome Assessment Data Changes This webinar presents an overview of the published article in the Journal of the Society for Clinical Data Management that...
January 9, 2024 C-Path Appoints Dr. Klaus Romero as New CEO Longtime quantitative medicine and regulatory science expert to spearhead C-Path's collaborative efforts in accelerating...
December 21, 2023 Flexible approaches to eCOA administration in clinical trials: The site perspective The Critical Path Institute convened the Support Flexible Approaches to PRO Data Collection project as part of the eCOA: Gettin
December 21, 2023 Flexible approaches to eCOA administration in clinical trials: The site perspective
